Peptide therapeutics (University of Arizona/ProNeurogen)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NamePeptide therapeutics (University of Arizona/ProNeurogen)
Drug Alias NamePNA-1
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionProto-oncogene Mas agonists
TargetsProto-oncogene Mas
Therapy Area/IndicationsCognition DisordersDementia, Vascular
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesThe University Of Arizona
China Registration ClassN/A

Develop Information

Active CompaniesProneurogenThe University Of Arizona
Inactive CompaniesN/A
Active IndicationsCognition DisordersDementia, Vascular
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A